| Impact of the COVID-19 pandemic on emergency department visits—United States, January 1, 2019–May 30, 2020 KP Hartnett MMWR. Morbidity and mortality weekly report 69, 2020 | 1167 | 2020 |
| Prevalence of nontuberculous mycobacterial lung disease in US Medicare beneficiaries J Adjemian, KN Olivier, AE Seitz, SM Holland, DR Prevots American journal of respiratory and critical care medicine 185 (8), 881-886, 2012 | 735 | 2012 |
| Emergency department visits for suspected suicide attempts among persons aged 12–25 years before and during the COVID-19 pandemic—United States, January 2019–May 2021 E Yard MMWR. Morbidity and mortality weekly report 70, 2021 | 646 | 2021 |
| Trends in US emergency department visits for mental health, overdose, and violence outcomes before and during the COVID-19 pandemic KM Holland, C Jones, AM Vivolo-Kantor, N Idaikkadar, M Zwald, B Hoots, ... JAMA psychiatry 78 (4), 372-379, 2021 | 572 | 2021 |
| Difficult-to-treat resistance in gram-negative bacteremia at 173 US hospitals: retrospective cohort analysis of prevalence, predictors, and outcome of resistance to all first … SS Kadri, J Adjemian, YL Lai, AB Spaulding, E Ricotta, DR Prevots, ... Clinical Infectious Diseases 67 (12), 1803-1814, 2018 | 429 | 2018 |
| Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007 AE Seitz, KN Olivier, J Adjemian, SM Holland, DR Prevots Chest 142 (2), 432-439, 2012 | 388 | 2012 |
| Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy EMN Ferre, SR Rose, SD Rosenzweig, PD Burbelo, KR Romito, ... JCI insight 1 (13), 2016 | 306 | 2016 |
| Update: interim guidance for health care providers evaluating and caring for patients with suspected e-cigarette, or vaping, product use associated lung injury—United States … DA Siegel MMWR. Morbidity and mortality weekly report 68, 2019 | 304 | 2019 |
| National syndromic surveillance program community of practice. Impact of the COVID-19 pandemic on emergency department visits—United States, January 1, 2019–May 30, 2020 KP Hartnett, A Kite-Powell, J DeVies, MA Coletta, TK Boehmer, ... MMWR Morb Mortal Wkly Rep 69 (23), 699-704, 2020 | 284 | 2020 |
| Incidence and prevalence of nontuberculous mycobacterial lung disease in a large US managed care health plan, 2008–2015 KL Winthrop, TK Marras, J Adjemian, H Zhang, P Wang, Q Zhang Annals of the American Thoracic Society 17 (2), 178-185, 2020 | 249 | 2020 |
| Severe pulmonary disease associated with electronic-cigarette–product use—interim guidance JG Schier MMWR. Morbidity and mortality weekly report 68, 2019 | 225 | 2019 |
| Characteristics of a multistate outbreak of lung injury associated with e-cigarette use, or vaping—United States, 2019 CG Perrine MMWR. Morbidity and Mortality Weekly Report 68, 2019 | 220 | 2019 |
| Spatial clusters of nontuberculous mycobacterial lung disease in the United States J Adjemian, KN Olivier, AE Seitz, JO Falkinham III, SM Holland, ... American journal of respiratory and critical care medicine 186 (6), 553-558, 2012 | 219 | 2012 |
| Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors … SS Kadri, YL Lai, S Warner, JR Strich, A Babiker, EE Ricotta, ... The Lancet Infectious Diseases 21 (2), 241-251, 2021 | 196 | 2021 |
| Trends in COVID-19 cases, emergency department visits, and hospital admissions among children and adolescents aged 0–17 years—United States, August 2020–August 2021 DA Siegel MMWR. Morbidity and Mortality Weekly Report 70, 2021 | 175 | 2021 |
| Outbreak of Marburg hemorrhagic fever among miners in Kamwenge and Ibanda Districts, Uganda, 2007 J Adjemian, EC Farnon, F Tschioko, JF Wamala, E Byaruhanga, GS Bwire, ... The Journal of infectious diseases 204 (suppl_3), S796-S799, 2011 | 159 | 2011 |
| The burden of pulmonary nontuberculous mycobacterial disease in the United States SE Strollo, J Adjemian, MK Adjemian, DR Prevots Annals of the American Thoracic Society 12 (10), 1458-1464, 2015 | 158 | 2015 |
| Lack of adherence to evidence-based treatment guidelines for nontuberculous mycobacterial lung disease J Adjemian, DR Prevots, J Gallagher, K Heap, R Gupta, D Griffith Annals of the American Thoracic Society 11 (1), 9-16, 2014 | 157 | 2014 |
| Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis AM Binder, J Adjemian, KN Olivier, DR Prevots American journal of respiratory and critical care medicine 188 (7), 807-812, 2013 | 156 | 2013 |
| Nontuberculous mycobacteria among patients with cystic fibrosis in the United States. Screening practices and environmental risk J Adjemian, KN Olivier, DR Prevots American journal of respiratory and critical care medicine 190 (5), 581-586, 2014 | 153 | 2014 |